10.25.21
Update: Johnson & Johnson ranks at #7 on our latest report Top 20 Global Beauty Companies 2022.
Johnson & Johnson is #10 on this year's list of Top Global Beauty Companies.
Below is a look at the company's 2021 highlights, recent acquisitions, best-selling brands, and latest innovations.
Corporate Sales
$82 billion
Skin Health/Beauty, Baby
$6 billion
Key Personnel
Alex Gorsky, chairman and chief executive officer; Thibaut Mongon, executive vice president, worldwide chairman, consumer health; Kathy Wengel, executive vice president and chief global supply chain officer
Major Products/Brands
Baby: Johnson’s; Beauty: Aveeno, Clean & Clear, Dr.Ci:Labo, Johnson’s, Le Petite Marseillais, Lubriderm, Neutrogena, OGX, Sundown; Oral Care: Listerine
New Products
Cottontouch Creamy Baby Oil, Shea & Cocoa Butter Creamy Baby Oil, Moisturizing Almond Oil for Dry Skin, Aveeno Hair Care, Aveeno Calm & Restore for Sensitive Skin, Neutrogena Clear Coverage, Neutrogena Healthy Scalp Clarify & Shine Scalp Scrub
Comments
In a year dominated by the launch and focus on their one-dose Covid-19 vaccine, J&J’s corporate sales dipped less than 1%.
Its Skin Health/Beauty segment fell 3.1% to $4.5 billion, which the company chalked up to the Covid-related impacts and SKU rationalization partially offset by growth in e-commerce and new product innovation. Skin Health/Beauty consumer sales decreased -1.7% in the U.S., -4.6% internationally, and 3.1% worldwide.
J&J’s Baby Care segment racked up sales of $1.5 billion in 2020, a decrease of 9.4% in comparison to 2019, which the company attributed to Covid-19 related impacts, SKU rationalization and the Baby Center divestiture in the U.S. partially offset by strength in the Aveeno Baby brand. Baby Care consumer sales grew 3.7% in the U.S., but fell -13.1% internationally and -9.4% worldwide.
Oral Care was a shining light, with franchise sales increasing 7.4% to $1.6 billion. The segment was driven by sales of Listerine mouthwash due to U.S. e-commerce and club channel growth, increased stocking demand related to Covid-19 and new product launches in the Asia Pacific region. Oral care consumer sales grew +9.9% in the US, +5.7% internationally, and +7.4% worldwide.
2021 Highlights
In April, J&J launched Neutrogena Studio, a dedicated branded content studio that will produce original programming designed to “educate about the science behind skin health, celebrate beauty for all and inspire people to action.” With actress Kerry Washington as its brand ambassador, the studio released “In the Sun,” a documentary that follows seven families to showcase the long-term effects of sun exposure on the skin. The doc includes input from dermatologist, Dr. Shirley Chi, who advises on “simple, but safe, ways to enjoy the beauty of sunshine.”
In July, Neutrogena launched Neutrogena Healthy Scalp, a collection of shampoos and conditioners formulated to bring “the science of skin care to scalp and haircare.” The haircare expansion was developed through an in-house collaboration at Johnson & Johnson Consumer Health between Neutrogena and the hair care experts at Vogue International, makers of OGX and Maui Moisture. According to the company, the idea behind the new collection was driven by the growing “skinification” of haircare and a shifting consumer desire to approach haircare with more than just strand health. “Non-medicated Neutrogena Healthy Scalp starts with a healthy, gentle daily approach to overall scalp and hair health, while traditional haircare focuses on the strand, and therapeutic scalp solutions are tailored to address specific scalp concerns,” the brand stated.
July also saw J&J issue a voluntary recall of 5 types of its Neutrogena and Aveeno aerosol sunscreens due to the presence of benzene, which is classified as a human carcinogen that can be absorbed by inhalation, through the skin and orally. A company statement said that while benzene is not an ingredient in any of its sunscreen products, it was detected in some samples of the impacted aerosol sunscreen finished products. They pledged to investigate the origin of the issue.
Looking Ahead
In Q1 2021, corporate sales rose almost 8% to just over $22.3 billion. Skin Health/Beauty sales rose 4.1% to more than $1.1 billion, while Oral Care sales increased 5.7% to $417 million and Baby Care sales increased 7.7% to $389 million.
In August, Johnson & Johnson announced that Joaquin Duato would replace Alex Gorsky, as CEO effective January 3, 2022. Gorsky will continue to serve as executive chairman. Duato has been with J&J for more than 30 years, serving most recently as the vice chairman of the executive committee, and as a provider of strategic direction for the Pharmaceutical and Consumer Health sectors and oversees the Global Supply Chain, Technology and Health & Wellness teams. Duato will also be appointed as a member of the company’s board of directors.
Read Next: Kao is #11.
Johnson & Johnson is #10 on this year's list of Top Global Beauty Companies.
Below is a look at the company's 2021 highlights, recent acquisitions, best-selling brands, and latest innovations.
Corporate Sales
$82 billion
Skin Health/Beauty, Baby
$6 billion
Key Personnel
Alex Gorsky, chairman and chief executive officer; Thibaut Mongon, executive vice president, worldwide chairman, consumer health; Kathy Wengel, executive vice president and chief global supply chain officer
Major Products/Brands
Baby: Johnson’s; Beauty: Aveeno, Clean & Clear, Dr.Ci:Labo, Johnson’s, Le Petite Marseillais, Lubriderm, Neutrogena, OGX, Sundown; Oral Care: Listerine
New Products
Cottontouch Creamy Baby Oil, Shea & Cocoa Butter Creamy Baby Oil, Moisturizing Almond Oil for Dry Skin, Aveeno Hair Care, Aveeno Calm & Restore for Sensitive Skin, Neutrogena Clear Coverage, Neutrogena Healthy Scalp Clarify & Shine Scalp Scrub
Comments
In a year dominated by the launch and focus on their one-dose Covid-19 vaccine, J&J’s corporate sales dipped less than 1%.
Its Skin Health/Beauty segment fell 3.1% to $4.5 billion, which the company chalked up to the Covid-related impacts and SKU rationalization partially offset by growth in e-commerce and new product innovation. Skin Health/Beauty consumer sales decreased -1.7% in the U.S., -4.6% internationally, and 3.1% worldwide.
J&J’s Baby Care segment racked up sales of $1.5 billion in 2020, a decrease of 9.4% in comparison to 2019, which the company attributed to Covid-19 related impacts, SKU rationalization and the Baby Center divestiture in the U.S. partially offset by strength in the Aveeno Baby brand. Baby Care consumer sales grew 3.7% in the U.S., but fell -13.1% internationally and -9.4% worldwide.
Oral Care was a shining light, with franchise sales increasing 7.4% to $1.6 billion. The segment was driven by sales of Listerine mouthwash due to U.S. e-commerce and club channel growth, increased stocking demand related to Covid-19 and new product launches in the Asia Pacific region. Oral care consumer sales grew +9.9% in the US, +5.7% internationally, and +7.4% worldwide.
2021 Highlights
In April, J&J launched Neutrogena Studio, a dedicated branded content studio that will produce original programming designed to “educate about the science behind skin health, celebrate beauty for all and inspire people to action.” With actress Kerry Washington as its brand ambassador, the studio released “In the Sun,” a documentary that follows seven families to showcase the long-term effects of sun exposure on the skin. The doc includes input from dermatologist, Dr. Shirley Chi, who advises on “simple, but safe, ways to enjoy the beauty of sunshine.”
In July, Neutrogena launched Neutrogena Healthy Scalp, a collection of shampoos and conditioners formulated to bring “the science of skin care to scalp and haircare.” The haircare expansion was developed through an in-house collaboration at Johnson & Johnson Consumer Health between Neutrogena and the hair care experts at Vogue International, makers of OGX and Maui Moisture. According to the company, the idea behind the new collection was driven by the growing “skinification” of haircare and a shifting consumer desire to approach haircare with more than just strand health. “Non-medicated Neutrogena Healthy Scalp starts with a healthy, gentle daily approach to overall scalp and hair health, while traditional haircare focuses on the strand, and therapeutic scalp solutions are tailored to address specific scalp concerns,” the brand stated.
July also saw J&J issue a voluntary recall of 5 types of its Neutrogena and Aveeno aerosol sunscreens due to the presence of benzene, which is classified as a human carcinogen that can be absorbed by inhalation, through the skin and orally. A company statement said that while benzene is not an ingredient in any of its sunscreen products, it was detected in some samples of the impacted aerosol sunscreen finished products. They pledged to investigate the origin of the issue.
Looking Ahead
In Q1 2021, corporate sales rose almost 8% to just over $22.3 billion. Skin Health/Beauty sales rose 4.1% to more than $1.1 billion, while Oral Care sales increased 5.7% to $417 million and Baby Care sales increased 7.7% to $389 million.
In August, Johnson & Johnson announced that Joaquin Duato would replace Alex Gorsky, as CEO effective January 3, 2022. Gorsky will continue to serve as executive chairman. Duato has been with J&J for more than 30 years, serving most recently as the vice chairman of the executive committee, and as a provider of strategic direction for the Pharmaceutical and Consumer Health sectors and oversees the Global Supply Chain, Technology and Health & Wellness teams. Duato will also be appointed as a member of the company’s board of directors.
Read Next: Kao is #11.